Reference health
COVID‐19 in DMARD‐treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database
18 of 35 checkable references need attention · checked 2026-07-23
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
does not resolve to a known work10.1016/S0140‐6736(20)30566‐3
does not resolve to a known work10.1186/1471‐2474‐13‐158
does not resolve to a known work10.1136/annrheumdis‐2020‐217871
does not resolve to a known work10.1136/annrheumdis‐2020‐217948
does not resolve to a known work10.1136/annrheumdis‐2020‐217460
does not resolve to a known work10.2165/00002018‐199920020‐00002
does not resolve to a known work10.1111/j.1365‐2125.2011.04037.x
does not resolve to a known work10.1007/s40264‐013‐0063‐5
does not resolve to a known work10.1136/bmjopen‐2017‐021447
does not resolve to a known work10.1007/s11926‐008‐0062‐1
does not resolve to a known work10.1016/s0140‐6736(20)30858‐8
does not resolve to a known work10.1002/JLB.3COVR0520‐272R
does not resolve to a known work10.1136/annrheumdis‐2020‐217615
does not resolve to a known work10.1007/s10067‐020‐05073‐9
does not resolve to a known work10.1136/gutjnl‐2019‐318484
does not resolve to a known work10.1136/annrheumdis‐2019‐216655
does not resolve to a known work10.1136/annrheumdis‐2020‐217159
does not resolve to a known work10.1136/annrheumdis‐2016‐210770
The 17 checked references that resolve
resolves10.1001/jama.2020.6775
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
resolves10.1001/jama.2020.2648
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
resolves10.1001/jama.2020.5394
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
resolves10.1002/acr.21812
Serious infections in a population‐based cohort of 86,039 seniors with rheumatoid arthritis
resolves10.1016/j.cmi.2017.12.025
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)
resolves10.1016/j.semarthrit.2020.05.010
COVID-19 in rheumatic disease patients on immunosuppressive agents
resolves10.1002/art.41388
Incidence of COVID‐19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?
resolves10.1136/ard.58.2008.i32
The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease
resolves10.4049/jimmunol.170.10.5210
The Lymphotoxin β Receptor Is Critically Involved in Controlling Infections with the Intracellular Pathogens
<i>Mycobacterium tuberculosis</i>
and
<i>Listeria monocytogenes</i>
resolves10.1182/blood.V85.10.2779.bloodjournal85102779
Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice
resolves10.1001/jama.2009.146
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
resolves10.1016/j.ijantimicag.2020.105954
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
resolves10.1016/j.jaut.2020.102442
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
The 1 reference without a DOI — listed, not checked
no DOI — not checkedTNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1111/fcp.12695"><img src="https://citestamp.com/citestamped/10.1111/fcp.12695/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1111/fcp.12695)